Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11658017 | 0.80 | GAA (0.35) | GAAMGAMSIMGAM2HCAR2 | |
| SCHEMBL5334245 | 0.80 | GAA (0.42) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL14488940 | 0.79 | HCAR2 (0.38) | HCAR2ALDH1A1L3MBTL1LMNAHSD17B10 | |
| SCHEMBL4955164 | 0.79 | GAA (0.38) | GAAMGAMSIMGAM2HCAR2 | |
| SCHEMBL4955169 | 0.79 | GAA (0.38) | GAAMGAMSIMGAM2HCAR2 | |
| SCHEMBL93928 | 0.78 | GAA (0.41) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL7713280 | 0.78 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL8755750 | 0.77 | GAA (0.39) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL27963209 | 0.77 | GAA (0.39) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL8213559 | 0.76 | ALDH1A1 (0.44) | GAAMGAMSIMGAM2HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10829597-B2 | Method for the preparation of organopolysiloxanes having (meth)acrylate functions | ELKEM SILICONES FRANCE SAS (FR) | 2020-11-10 | — | — | US | disclosed |
| US-20190135983-A1 | METHOD FOR THE PREPARATION OF ORGANOPOLYSILOXANES HAVING (METH)ACRYLATE FUNCTIONS | ELKEM SILICONES FRANCE SAS (FR) | 2019-05-09 | — | — | US | disclosed |
| CN-109640924-A | Photocurable composition | 株式会社德山齿科 | 2019-04-16 | — | — | CN | disclosed |
| CN-106413665-A | Bonding method, bonding kit, and bonding material | 德山齿科株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-20100278925-A1 | FORMULATIONS OF ORGANO-PLATINIC COMPOUNDS IN THE PRESENCE OF ASSOCIATIVE POLYMERS, PRODUCTS THUS OBTAINED AND USES THEREOF | Coatex S.A. S. (FR) | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278925-A1 | FORMULATIONS OF ORGANO-PLATINIC COMPOUNDS IN THE PRESENCE OF ASSOCIATIVE POLYMERS, PRODUCTS THUS OBTAINED AND USES THEREOF | PGC, IPO4, IPO5 | GAA 1726/4885MGAM 3185/4885SI 1150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.